These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 1436605)

  • 1. [The use of thymopentin in preventing acute infectious relapses in elderly subjects with COPD].
    Valenzano C; Megale N; Icardi M; Arione R; Cadario G
    Minerva Med; 1992 Sep; 83(9):545-8. PubMed ID: 1436605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Thymic hormone treatment of acute and chronic respiratory infections in the elderly].
    Agostinelli M; Zaia AM; Fiorentini A; Stecconi R; Fabris N; Scalise G
    Recenti Prog Med; 1989; 80(7-8):438-41. PubMed ID: 2682857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The use of thymopentin in the prevention of recurrent infections of the respiratory system. Multicenter study].
    Tovo PA; De Martino M; Rossi P; Cavagni G; Masi M; Bardare M
    Minerva Pediatr; 1993 Dec; 45(12):505-10. PubMed ID: 8145686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Variations of the immunological parameters and the clinical response in 25 children treated with thymopentin].
    Melaranci C; Giammaria P
    Pediatr Med Chir; 1991; 13(6):609-12. PubMed ID: 1806920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aerosol thymopentin in the prevention of relapse of chronic bronchitis].
    Chianese R; Bilancia RA; Majorano V; Ricatti DG; Cantacessi G; Ricchiuto GL; Infantino MP; Gramiccioni E
    Arch Monaldi Mal Torace; 1992; 47(1-6):41-5. PubMed ID: 1306635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A clinico-epidemiological study on the efficacy of thymopentin therapy in patients with chronic bronchitis and cellular immunity deficiency].
    Amoroso A; Di Rosa R; Guidotti G; Ferri GM; Afeltra A
    Recenti Prog Med; 1990 Jan; 81(1):29-32. PubMed ID: 2236822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevention of immunodeficiency and postoperative infective complications in patients undergoing surgical resection for carcinoma of the colon-rectum. Clinical study on 50 cases, using thymus hormones and thymopentin in particular].
    Elia P; Lombardo G; Delpiano C; Granello M
    Minerva Chir; 1994 Jun; 49(6):575-80. PubMed ID: 7970063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic effectiveness of bamifylline in elderly patients with COPD].
    Cogo R; Monzani GP; Fusillo M; Vota M
    Minerva Med; 1991 Mar; 82(3):115-8. PubMed ID: 2006029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe exacerbations of COPD patients: the role of pulmonary infections.
    Fagon JY; Chastre J
    Semin Respir Infect; 1996 Jun; 11(2):109-18. PubMed ID: 8776780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicology and carcinogenesis studies of indium phosphide (CAS No. 22398-90-7) in F344/N rats and B6C3F1 mice (inhalation studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2001 Jul; (499):7-340. PubMed ID: 12087422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP Toxicology and Carcinogenesis Studies of Tetrafluoroethylene (CAS No. 116-14-3) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 Apr; 450():1-321. PubMed ID: 12594525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recurrent infections of the urogenital tract: preliminary results of a study on the clinical and immunological effects of thymopentin treatment].
    Amoroso A; Di Rosa R; Ferri GM; Afeltra A; Mola A; Pietrucci A; Reverberi L; Bonomo L
    Boll Ist Sieroter Milan; 1989; 68(3):249-54. PubMed ID: 2491433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of the use of thymopentin in patients with progressive systemic sclerosis].
    Giordano N; Biasi G; Vaccai D; Morozzi G; Marcolongo R; Bertelletti D
    Clin Ter; 1991 Mar; 136(6):399-407. PubMed ID: 1828204
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymopentin prophylactic treatment in patients with recurrent respiratory infections.
    Sundal E
    Br J Clin Pract; 1993; 47(4):198-204. PubMed ID: 8260339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent acute otitis media occurring within one month from completion of antibiotic therapy: relationship to the original pathogen.
    Leibovitz E; Greenberg D; Piglansky L; Raiz S; Porat N; Press J; Leiberman A; Dagan R
    Pediatr Infect Dis J; 2003 Mar; 22(3):209-16. PubMed ID: 12634580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation between pulmonary pharmacokinetics and pharmacodynamics support the hypothesis of the usefulness of ceftazidime at a single 1g daily dose in the treatment of bacterial exacerbation of chronic obstructive bronchopneumonia with moderate functional damage].
    Cazzola M; Noschese P; Vinciguerra A; Di Perna F; Califano C; Berra A
    Minerva Med; 1998; 89(1-2):15-22. PubMed ID: 9561021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.